Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001443515 | SCV001646488 | likely benign | Deficiency of aromatic-L-amino-acid decarboxylase | 2024-11-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002559306 | SCV003552755 | likely benign | Inborn genetic diseases | 2022-05-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Centre de Biologie Pathologie Génétique, |
RCV001527605 | SCV001738715 | uncertain significance | Global developmental delay | 2020-01-01 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003920954 | SCV004736518 | likely benign | DDC-related disorder | 2019-05-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |